Obesity Management Market Forecast to 2032: Exploring Key Drivers, Challenges, and Regional Trends

The obesity management market size is projected to expand at 8.4% CAGR to reach USD 2.85 billion during the forecast period 2023-2032.

The Obesity Management Market is witnessing significant growth, driven by the increasing prevalence of obesity worldwide. As lifestyles become more sedentary and dietary patterns shift towards high-calorie, processed foods, obesity has emerged as a global health concern. The market encompasses various approaches to address obesity, ranging from lifestyle interventions to pharmacotherapy and surgical procedures.

One notable segment within the Obesity Management Market is Pediatric Weight Management. Childhood obesity has reached alarming levels, necessitating specialized interventions to curb the long-term health implications. Pediatric weight management focuses on promoting healthy lifestyles, incorporating nutritional education, physical activity, and behavioral changes tailored to the unique needs of children and adolescents.

The Obesity Weight Management sector, a broader component of the market, encompasses solutions for both adults and children. It includes a spectrum of interventions such as diet plans, exercise regimens, pharmaceutical options, and, in extreme cases, surgical procedures. The goal is not only weight reduction but also addressing associated health risks like diabetes, cardiovascular diseases, and metabolic disorders.

As awareness about the adverse effects of obesity grows, the demand for effective weight management solutions is expected to rise. Key players in the market are investing in research and development to introduce innovative therapies and interventions. The Pediatric Weight Management and Obesity Weight Management segments are crucial elements in this dynamic market, reflecting a comprehensive approach to tackling the multifaceted challenges posed by obesity across different age groups.

Top of Form

Top of Form

Major Key Players:

Pfizer Inc. (U.S.), Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), GlaxoSmithKline plc. (U.K), AstraZeneca plc (U.K), Herbalife Ltd. (U.S.), Apollo Endosurgery (U.S.), Ethicon, Inc. (U.S.) are some of the Obesity Management Market Players, globally.

Segmental Overview

The segmental analysis of the global obesity management market has been conducted on the basis of prescription, surgery and lifestyle changes.

Based on prescription, the market has been segmented into lorcaserin (Belviq), buproprion and naltrexone (Contrave), liraglutide (Saxenda), orlistat (Xenical), phentermine and topiramate (Qsymia) and others. Based on surgery, the market has been segmented into Biliopancreatic diversion with duodenal switch, Laparoscopic adjustable gastric banding (LAGB), Gastric bypass surgery and others. Based on lifestyle changes, the market has been segmented into exercise, dietary changes and others.

Regional Analysis

The market of obesity management is growing rapidly in Asia Pacific region, owing to poor diet, lack of physical activity, and unhealthy life balance. These are the factor which leads the obesity population in this region. Most of the countries of this region have common lifestyle and economic conditions, So the factor introduce above have common with in this region and leads the patient population. Government of developing countries within this region are more focusing towards new technology and advance treatment option, thus more research and development programs are initiated for the development of new drugs.  These are the factors which are fuelling the growth of the market of obesity managements with the significant rates. These advance treatment will overcome the saturation that occurs during last few years. Countries like India and china are more focused market for global market players owing to huge patient population and growing purchasing power as compare to other countries in this region. The market of obesity management is much higher in the Americas region attribute to high presence of obesity population along with developed treatment option. According to CDC, 37.9% of adults over 20 years were suffering with the obesity between 2013 and 2014 and 70.7% of adults aged 20 years and over were suffering with overweight, including obesity. These stats show the opportunity of market players within the Americas region.

For More Information, Please Visit @ Market Research Future

Comments

Post a Comment

Popular posts from this blog

Impact of COVID-19 Outbreak on Medical Billing Outsourcing Market – Industry Share Report 2027

  Medical Billing Outsourcing Market The growing emphasis on compliance and risk management and global expansion of some of the key players are some of the key factors driving the Medical Billing Outsourcing Market. In 2016, Allscripts acquired Core Medical Solutions, to increase its offerings in Australia. Allscripts currently supports more than 85 hospitals throughout Australia. Various other factors such as rising healthcare expenditure, increasing government support, and technological advancements are also expected to propel the growth of the market. The global  Medical Billing Outsourcing Market   is expected to grow at an approximate CAGR of 12.5% during the forecast period. However, increasing legislative & regulatory pressure, untapped emerging markets, Major Key Players: Some of the key players in the global Medical Billing Outsourcing Market are R1 RCM Inc., Allscripts, Cerner Corporation, EClinical Works, Experian Information Solutions Inc., GENERAL EL...
Read more

Global Microcarriers Market Size 2021 Expeditious Growth, Opportunities and forecast to 2027

  Microcarriers Market 2021 The Global  Microcarrier Market   Size  is anticipated to hold a market value of USD 1.18 billion with an estimated CAGR of 5.9% during the forecast period. A microcarrier is a support matrix allowing the growth of adherent cells. The microcarrier system provides high cell yields without having to resort to bulky equipment and tedious methodology. The rise in the use of microcarrier technology for various cell-based applications, coupled with the advantages of the microcarrier system such as its support for high yield of cells, facilitation of polarization and differentiation of cells, and lower risk of contamination are expected to drive the growth of the market during the forecast period. Moreover, the rapid growth of the biologics industry also fuels the growth of this market. On the other hand, strict regulatory framework, and limitation in production of high-density cell culture may hinder the growth of the market during the fore...
Read more

Non-Surgical Solutions on the Rise: Skin Tightening Market to Reach New Heights by 2032

The Skin Tightening Market is projected to grow from USD 1.13 Billion in 2023 to USD 3.3 billion by 2032, at a CAGR of 18.2% during the forecast. The global skin tightening market has witnessed significant growth in recent years, with a notable shift towards non-surgical and minimally invasive procedures. Consumers are increasingly seeking effective ways to rejuvenate their skin without the downtime and risks associated with traditional surgical methods. Non-surgical skin tightening and laser skin tightening have emerged as two prominent trends in this evolving market. Non-surgical skin tightening procedures utilize advanced technologies such as radiofrequency, ultrasound, and infrared light to stimulate collagen production and tighten the skin. These procedures are gaining popularity due to their minimal downtime, reduced risk of complications, and natural-looking results. Patients appreciate the convenience of non-surgical options that allow them to achieve a more youthful appe...
Read more